Depression in multiple sclerosis associated with interferon beta-1a (Rebif).
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000009:adverse effects*; D000328:Adult; D015283:Citalopram / Q000627:therapeutic use; D003866:Depressive Disorder / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D006801:Humans; D000068556:Interferon beta-1a; D016899:Interferon-beta / Q000008:administration & dosage / Q000009:adverse effects*; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy* / Q000523:psychology
D000276:Adjuvants, Immunologic; D015283:Citalopram; D016899:Interferon-beta; D000068556:Interferon beta-1a